CMS explains why it rejected GEMS’s bid to lower contribution increase
The CMS argues that a 7.5% increase would have weakened GEMS’s financial sustainability and shifted costs to members in future.
#medicalschemes
CMS reviewing Bonitas complaints, says recovery plan appears to be bearing fruit
The regulator says it is monitoring the situation and sees signs of improvement, but some members continue to report difficulties accessing healthcare and resolving claims.
The next frontier for employee benefits is integration
Sanlam’s Benchmark report argues that improving member outcomes increasingly depends on linking financial advice, healthcare, and risk benefits.
CMS rejects GEMS bid to cut 2026 contribution increase as unions demand answers
The regulator has rejected the scheme’s proposal to reduce its weighted average contribution adjustment to 7.5%, leaving the existing 9.5% increase in place.
Was it really just Covid?
A review of five years of Medihelp’s annual reports traces the events behind the scheme’s fall below and its rise back above the statutory minimum.
Medihelp’s turnaround: How the scheme rebuilt its business before its balance sheet
Twelve months after reporting a solvency ratio of just 20.99%, Medihelp returned above the statutory threshold while almost nine-folding its operating surplus.
Seven years of growth: What Bestmed’s numbers say about its sustainability
Membership, claims, reserves, and solvency all point to a strong year, but they also reveal the long-term pressures facing the scheme.
Discovery financially stronger, but beneficiary base shrinks again
DHMS improved its solvency, surplus and principal membership, but an ageing risk pool, fewer beneficiaries, and a claims-system error tempered the year’s progress.
High Court upholds medical schemes’ recovery powers
The ruling preserves a key anti-fraud tool that industry bodies say protects member funds and helps contain healthcare costs.
Mental health is reshaping the chronic disease equation
New findings suggest emotional well-being now plays a growing role in whether patients with diabetes, cancer, and heart disease stay stable and out of hospital.
What better healthcare could look like in South Africa
Discovery’s data shows how prevention, screening, and co-ordinated care can extend lives – while raising difficult questions about how to replicate those gains more widely.
The 11-year health gap: what adds – or costs – years of life
Discovery Health’s analysis of 2.7 million medical scheme members shows how earlier intervention, better treatment, and healthier lifestyles are reshaping life expectancy.
Bigger, older, and more concentrated: 7 facts reshaping medical schemes
Twenty years of industry data show that medical schemes have become increasingly dependent on scale, investment returns, and strong reserves to remain sustainable.
Medscheme rejects Bonitas’s explanation for post-transition disruptions
Medscheme says it repeatedly warned Bonitas against a ‘clean-cut’ transition and disputes the scheme’s claim that unresolved legacy issues were behind the service disruptions experienced by members after the administration switch.
Bonitas members caught in service disruption after administration switch
The medical scheme says legacy issues contributed to post-transition challenges as members report delays with hospital authorisations and medication approvals.
Not just inflation: the demographic shift driving medical scheme hikes
Shrinking younger membership is intensifying an ageing risk pool, pushing contributions higher even when hospital use is flat.
Bonitas: administrator change is part of a wider repositioning
The scheme says continuity of care remains the priority as it moves administration to Momentum Health and managed care to PHA on 1 June.
